Medicare Drug Negotiations

Business

AstraZeneca Shifts Gears: Full NYSE Listing Marks Strategic Pivot to US Market

The UK pharmaceutical giant AstraZeneca begins trading ordinary shares on the New York Stock Exchange today, a significant upgrade from its previous Nasdaq ADR listing. This move underscores the company's strategic rebalancing towards the United States, its largest market, and raises questions about the long-term relevance of its London listing.

Feb 2, 2026

Business

Immunocore's Valuation Puzzle: Short-Term Volatility Masks Long-Term Promise

Immunocore Holdings (IMCR) shares have experienced notable turbulence, declining over 7% in a week. Yet, a significant gap between its current price and analyst fair value estimates highlights a debate over the biotech's future, heavily reliant on its lead asset KIMMTRAK and pipeline execution.

Feb 2, 2026

Business

FDA Grants Breakthrough Status to Cogent Biosciences' GIST Combo Therapy, Accelerating Path to Market

Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.

Feb 2, 2026

World

Starmer Warns Against UK Isolationism on China Amid Trump's Transatlantic Pressure

UK Labour leader Keir Starmer urges sustained engagement with Beijing, countering Donald Trump's call for Western disengagement and highlighting deepening geopolitical divides.

Feb 2, 2026

World

Iran Escalates Diplomatic Row, Summons EU Ambassadors Over Revolutionary Guard Terror Designation

Iran has summoned the ambassadors of all European Union member states in Tehran in a sharp diplomatic protest against the bloc's move to formally designate the Islamic Revolutionary Guard Corps (IRGC) as a terrorist organization.

Feb 2, 2026

World

Shutdown Showdown: Speaker Johnson Navigates ICE Debate and Funding Impasse

With a partial government shutdown underway, House Speaker Mike Johnson confronts a dual crisis: securing passage of a federal funding package and mediating an intensifying political battle over the scope and tactics of Immigration and Customs Enforcement operations.

Feb 2, 2026

Business

Centene's $2.2M Chicago Housing Grant Fuels Debate on Corporate Strategy and Stock Valuation

A major grant from Centene's foundation aims to tackle housing insecurity for justice-involved individuals in Chicago, spotlighting the healthcare giant's community investments as its stock faces persistent headwinds.

Feb 2, 2026

Business

Takeda Lifts Full-Year Forecasts and Launches New PID Therapy, But Investor Debate on Valuation Intensifies

Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.

Feb 2, 2026

Business

February's Investment Spotlight: Three Stocks Poised for Growth in 2026

As markets navigate a new year, analysts are eyeing potential outperformers. Amazon, BeOne Medicines, and Enterprise Products Partners emerge as compelling picks, each backed by distinct catalysts from AI to biotech breakthroughs.

Feb 2, 2026

World

Iran Escalates Diplomatic Row, Summons EU Envoys Over Revolutionary Guard's Terror Listing

Iran has summoned the ambassadors of all European Union member states in Tehran in a sharp diplomatic protest against the bloc's recent decision to designate the Islamic Revolutionary Guard Corps (IRGC) as a terrorist organization. The move, triggered by the IRGC's alleged role in suppressing protests, deepens Iran's isolation amid heightened regional tensions.

Feb 2, 2026

World

Germany Grinds to a Halt: Nationwide Transport Strike Paralyzes Cities Amid Deep Freeze

A massive strike by public transport workers has brought buses and trams to a standstill across Germany, leaving commuters stranded in sub-zero temperatures as a bitter dispute over pay and conditions escalates.

Feb 2, 2026

Business

Intuitive Surgical's da Vinci 5 Gains FDA Nod for Cardiac Procedures, Expanding Robotic Surgery's Reach

The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.

Feb 2, 2026

Business

FDA Expands Glaukos' iDose TR Implant Approval, Paving Way for Repeat Use in Glaucoma Management

Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.

Feb 2, 2026

Business

Exelixis Stock: A Biotech Winner's Valuation Puzzle After Years of Stellar Gains

Exelixis shares have delivered impressive multi-year returns, but recent price weakness has investors questioning if the rally has run its course. A deep dive into valuation models suggests the stock may still be significantly undervalued, presenting a potential opportunity amidst market uncertainty.

Feb 2, 2026

World

Medvedev Warns of Global Alarm as New START Expiry Looms, Threatening First Unchecked Nuclear Era in Decades

Russia's former president Dmitry Medvedev cautions that the potential lapse of the last major U.S.-Russia nuclear arms treaty without a successor could plunge the world into an unprecedented era of strategic instability unseen since the Cold War.

Feb 2, 2026

World

Gaza Truce Talks Advance Amid Deadly Overnight Strikes; At Least 30 Palestinians Killed

As diplomatic efforts to secure a ceasefire in Gaza show fragile progress, Israeli airstrikes have resulted in the deaths of at least 30 Palestinians overnight, with multiple children among the casualties, according to local health authorities.

Feb 2, 2026

US

Weekend Rundown: Boy, 5, Released from Immigration Custody as Broader Policy Battle Rages On

A five-year-old boy, whose detention made him a symbol of U.S. immigration enforcement, has been released with his father. Their case highlights the ongoing political stalemate over border policy and government funding, with a partial shutdown looming.

Feb 2, 2026

Business

Takeda's Stock Surge Puts Valuation in Spotlight: Is the Pharma Giant Overpriced or Undervalued?

Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.

Feb 2, 2026

Business

Bank of America Navigates Legal Storm and Digital Future Amid Epstein Lawsuit and Stablecoin Policy Talks

As a federal judge advances a lawsuit tying Bank of America to Jeffrey Epstein's sex trafficking network, the financial giant simultaneously positions itself at the forefront of stablecoin regulation discussions with Coinbase and the White House, creating a complex risk-and-opportunity landscape for investors.

Feb 2, 2026

Business

Beneath the Radar: Three Asian Small-Caps Under $200M Drawing Investor Scrutiny

Amidst shifting economic currents in Asia, a class of smaller companies—often overlooked as 'penny stocks'—is attracting attention for their distinct financial profiles and niche market positions. We analyze three such firms with market capitalizations below US$200 million.

Feb 2, 2026